PTX 0.00% 4.4¢ prescient therapeutics limited

Ann: Encouraging data from PTX-200 ovarian cancer trial, page-50

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 11,703 Posts.
    lightbulb Created with Sketch. 1077
    I don't understand why this Ovarian Cancer results for phase 1B is not positive considering patient options for this un-treatable cancer. The results are very encouraging for sufferers.

    Hopefully the more advanced phase 2 results for breast cancer can demonstrate significant progress and benefit for the breast cancer sufferers.

    Nail biting stuff

 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.